Featured Research

from universities, journals, and other organizations

Quitting smokeless tobacco after heart attack may extend life expectancy

Date:
June 23, 2014
Source:
American Heart Association
Summary:
Quitting smokeless tobacco after a heart attack extends life expectancy similar to quitting smoking, researchers report. Study participants who stopped using the Swedish form of snuff after a heart attack reduced their risk of dying by nearly 50 percent.

“Snus” is moist Swedish smokeless powder tobacco.
Credit: Gabriel Arefalk, M.D.

People who stop using smokeless tobacco after a heart attack may extend their life expectancy similar to people who stop smoking, according to new research in the American Heart Association journal Circulation.

"We didn't expect to see such a strong association among those people who stopped using (smokeless tobacco)," said Gabriel Arefalk, M.D., lead researcher and cardiologist at Uppsala University Hospital in Uppsala, Sweden. "After a heart attack, no doubt smoking cessation reduces the risk of death approximately one third and is really a cornerstone of cardiac rehabilitation worldwide. For smokeless tobacco, we did not know."

This may be the first study to examine the impact of smokeless tobacco on death in heart attack survivors.

Researchers analyzed the effect of quitting the use of snus, a moist Swedish smokeless powder tobacco kept under the upper lip. It's a variant of snuff, but doesn't need to be spit out.

They reviewed data on heart attack survivors younger than 75 in Sweden in 2005-09 and identified 2,474 snus users. Of those, 675 quit using snus. During two years of follow-up, 14 snus-quitters died and 69 of those who continued using snus died. In a mathematical analysis estimating the number of people who die in 1,000 years, researchers determined that the death rate was 9.7 per 1,000 person-years at risk for snus quitters and 18.7 for snus users.

After considering factors like age, gender, other tobacco use, occupation and participation in a cardiac rehabilitation program, researchers said those who stopped using snus had nearly half the mortality risk, similar to the benefit observed with smoking cessation.

Although the study focused on snus, Arefalk said nicotine levels are comparable to levels in snuff.

Snuff use is increasing worldwide. In the largest market, the United States, about 1.7 billion cans are consumed each year. The largest concentration of a population (prevalence) using snuff is in Sweden, where 20 percent of men and 3 percent of women use snus daily.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. G. Arefalk, K. Hambraeus, L. Lind, K. Michaelsson, B. Lindahl, J. Sundstrom. Discontinuation of Smokeless Tobacco and Mortality Risk after Myocardial Infarction. Circulation, 2014; DOI: 10.1161/CIRCULATIONAHA.113.007252

Cite This Page:

American Heart Association. "Quitting smokeless tobacco after heart attack may extend life expectancy." ScienceDaily. ScienceDaily, 23 June 2014. <www.sciencedaily.com/releases/2014/06/140623161809.htm>.
American Heart Association. (2014, June 23). Quitting smokeless tobacco after heart attack may extend life expectancy. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2014/06/140623161809.htm
American Heart Association. "Quitting smokeless tobacco after heart attack may extend life expectancy." ScienceDaily. www.sciencedaily.com/releases/2014/06/140623161809.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins